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Summary 
Background: The aim of this study was to determine the
reference values for thyrotropin (TSH), thyroid hormones
(total and free thyroxine, T4 and fT4; total and free tri-
iodothyronine, T3 and fT3), thyroglobulin (Tg) and thyroid
antibodies (thyroid peroxidase, TPOAb and thyroglobulin
antibody, TgAb) in the population of the Republic of
Srpska.
Methods: A total of 250 euthyroid subjects were enrolled in
this study. A direct method for choosing reference subjects
was used to establish reference intervals. The hormones
and thyroid antibodies were measured by an electrochemi-
luminescence immunoassay method (ECLIA, Roche
Diagnostics, Mannheim, Germany). We calculated the re f -
erence intervals by MedCalc, version 12.1.4.0 (MedCalc
software, Belgium) as recommended by the IFCC (CLSI
C28-A3). 
Results: Using guidelines recommended by the National
Academy of Clinical Biochemistry (NACB) and based on
standard statistical approaches, the reference intervals
derived for TSH, fT4, T4, fT3, T3 were 0.75–5.32 mIU/L,
12.29–20.03 pmol/L, 73.49–126,30 nmol/L, 4.11–6.32
pmol/L, 1.15–2.32 nmol/L and  for Tg, TPOAb, TgAb were
3.63–26.00 mg/L, <18.02 mIU/L, < 98.00 mIU/L, respe -
ctively. We found a significant difference (p<0.05) in TSH
and fT3 values between different age groups as well as in
T4, fT4 and fT3 values between ge nder groups. 
Kratak sadr`aj
Uvod: Cilj ovog rada bio je da se utvrde referentne vred -
nosti tireotropnog hormona (TSH), tireoidnih hormona
(ukupni tiroksin, T4 i slobodni tiroksin, fT4; ukupni trijod -
tironin, T3 i slobodni trijodtironin, fT3), tireoglobulina (Tg)
i anti tela {titne `lezde (antitela na tireoperoksidazu, TPO-At
i tireoglobulinska antitela, Tg-At) kod stanovni{tva Re pu -
blike Srpske. 
Metode: Ukupno 250 eutireoidnih ispitanika bilo je uklju -
~eno u ovo istra`ivanje. Kori{}en je direktan na~in izbora
referentnih osoba za utvr|ivanje referentnog intervala.
Hor moni i antitela {titne `lezde odre|ivani su u serumu
elektrohemiluminiscentnom metodom (ECLIA, Roche
Diag nostics, Mannheim, Germany). Referentne granice su
odre|ene kori{tenjem programa MedCalc, verzija 12.1.4.0
(MedCalc software, Belgium) po preporuci IFCC (CLSI
C28-A3). 
Rezultati: Koriste}i smernice Nacionalne  akademije za  kli -
ni~ku biohemiju (NACB) i na temelju standardnih statističkih
pristupa utvr|eni referentni intervali za TSH, fT4, T4, fT3, T3
bili su 0,75–5,32 mIU/L, 12,29–20,03 pmol/L, 73,49–
126,30 nmol/L, 4.11–6.32 pmol/L, 1,15–2,32  nmol/L kao
i za Tg, TPOAt, TgAt  3,63–26,00 mg/L, <18,02 mIU/L, <
98,00 mIU/L. Tako|e, postojala je i zna~ajna razlika izme|u
razli~itih starosnih grupa za TSH i fT3 vrednosti, kao i razlika
za T4, fT4 i fT3 vrednosti izme|u `ena i mu{karaca.
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Introduction
The improvement of sensitivity and specificity of
biochemical thyroid tests has had a strong influence
on the clinical strategy for detecting and treating thy-
roid diseases in the last forty years. TSH is a first-line
test for the assessment of thyroid function, mainly due
to suspicion of subclinical hypothyroidism, if it is
determined by the third generation methods with a
functional sensitivity of 0.01 mIU/L (1).
To use this test, the following conditions must be
fulfilled as follows:
1. intact hypothalamic pituitary function 
2. stable thyroid status.
Since the clinical signs and symptoms are often
unclear and non-specific, in the case of increase or
deficiency of thyroid hormones (total and free thyrox-
ine, T4 and fT4; total and free triiodothyronine, T3
and fT3) laboratory determinations are necessary to
confirm hyperthyroidism or hypothyroidism. 
Thyroperoxidase (TPO) is a key enzyme in the
formation of thyroid hormones and a major autoanti-
gen in autoimmune thyroid diseases (2). Thyroid per-
oxidase antibodies (TPOAb) are very important for
the diagnosis of autoimmune diseases of the thyroid
gland, particularly Hashimoto’s disease. They are
often present in euthyroid subjects (prevalence of
12–26%) (3) and they are important for the evalua-
tion of future clinical status of euthyroid persons (4).
The measuring of TPOAb has much greater influence
than measuring of TgAb in euthyroid persons, which
can be used to identify people at increased risk of
hypothyroidism.
A reference interval is a range of reference val-
ues obtained in healthy individuals of the same or
similar characteristics. A direct or an indirect method
are most commonly used for the preparation of a ref-
erence interval. Using a direct method, reference per-
sons are selected from a reference population to pre-
cisely define the criteria. By using an indirect method,
instead of reference persons, values with the required
characteristics are selected from an existing database.
The direct method of selecting reference persons is in
line with the Clinical and Laboratory Standards In -
stitute/Inter na tional Federation of Clinical  Chemistry
and Labo ra tory Medicine (CLSI/IFCC) recommenda-
tion (5) and it can be applied in all situations, but its
lack is that the selection of a reference group is fol-
lowed by major problems and costs.
For example, the reference interval for TSH
should be determined in order to represent the limits
that are a 95% confidence interval of the log-trans-
formed values obtained by determining TSH in at
least 120 rigorously selected normal euthyroid volun-
teers, in whom no thyroid autoantibodies (TPOAb
and TgAb measured by sensitive immunoassays) were
detected, with no personal or family history of thyroid
dysfunction, with no visible palpable goiter and with
no medication (except estrogen) (6). The sample for
the determination of reference values should be
taken under conditions as similar as possible to the
conditions that exist in clinical practice. It is necessary
to conduct a complete standardization of the preana-
lytical conditions under which samples are taken in
order to reduce the random error. The basic rule
which must be complied with in the standardization of
these conditions is to control only those conditions
that significantly affect the intra- and inter-individual
variation, as well as those that are easy to control in
the clinical setting.
The preanalytical factors which affect the refer-
ence values can be divided into biological (prepara-
tion, or the patient’s condition prior to sampling and
time of sampling) and methodology (method of sam-
ple collection, transport and handling of the sample
prior to treatment and processing of the sample itself)
(6). The most of preanalytical factors have no impact
on the determination of TSH in the serum, as well as
the hormones of the thyroid gland. Physiological vari-
ables, individual variables such as genetic abnormali-
ties of thyroid binding proteins or variables present in
heavy non-thyroid diseases can affect determination.
Also, iatrogenic factors such as thyroid and non-thy-
roid drugs (glucocorticoids or beta blockers), the
presence of autoantibodies to the thyroid hormones
or heterophilic antibodies (human anti-mouse anti-
bodies, HAMA) can affect the diagnostic accuracy
(6). Variables such as gender, age, phase of the men-
strual cycle, smoking, exercise, taking a sample of
fasting or track during phlebotomy have minimum
impact on the reference intervals of thyroid tests with-
out patients (3). According to the fact that the differ-
ences in these physiological variables are less than
the differences of the method, they do not have
importance in the clinical practice. The aim of this
study was to determine the reference values for thyro -
tropin (TSH), thyroid hormones (total and free thyro -
Conclusions: The established reference values for the pop-
ulation of the Republic of Srpska were significantly different
from the values recommended by the manufacturer of
reagents (Roche Diagnostics). Our results showed that a
laboratory needs to establish its own reference values in
order to set up a proper diagnosis, as well as to treat
patients successfully.
Keywords: reference values, TSH, thyroid hormones
Zaklju~ak: Dobijene referentne vrednosti za populaciju Re -
publike Srpske znatno su se razlikovale od vrednosti pre-
poru~enih od strane proizvo|a~a reagensa (Roche Diag no -
stics). Rezultati su ukazali da laboratorije moraju da izrade
sopstvene referentne vrednosti sa ciljem postavljanja prave
dijagnoze, kao i uspe{nog le~enja pacijenata.
Klju~ne re~i: referentne vrednosti, TSH, hormoni {titne
`lezde
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xine, T4 and fT4; total and free triiodothyronine, T3
and fT3), thyroglobulin (Tg) and thyroid antibodies
(thyroid peroxidase, TPOAb and thyroglobulin anti-
body, TgAb) in the population of the Republic of
Srpska, because there are recommendations that
users should establish reference intervals for their
own population depending on the methods and
reagents used.
Materials and Methods
Subjects
A total of 250 participants were enrolled in this
study. The subjects were voluntarily included in the
study at the University Clinical Centre of the Republic
of Srpska, Banja Luka and Health Centre Lakta{i
(Banja Luka, Bosnia and Herzegovina). The study was
approved by the National Ethics Committee. Written
consent was obtained from the participating subjects.
The study included all subjects in which on the
basis of thorough history and physical examination,
as well as insight into existing medical records, a sick
condition could not be determined that would affect
change in the results of laboratory tests for which the
reference values were determined. Subjects on medi -
cation for thyroid diseases and subjects with a positive
history of thyroid diseases were excluded from this
study. Also, people who take medications that can
affect the hypothalamus-pituitary-thyroid gland
(amiodarone, glucocorticoids) were excluded from
the study. The final decision about a reference person
is given with the help of laboratory findings (accord-
ing to the NACB recommendation).
For the measurement of thyroid parameters in
serum, blood samples were taken in the morning
between 7:00 and 9:00 a.m. after 12–14 h of fasting.
Methods
The serum thyroid hormones and antibodies
concentration was measured by an electrochemilumi-
nescence immunoassay (ECLIA, Roche Diagnostics,
Mannheim, Germany). The reference range for the
TSH assay was from 0.27 to 4.2 mIU/L, and the
functional sensitivity provided by the manufacturer
was 0.014 mIU/L. The expected values for euthyroid
subjects were: 66–181 nmol/L of T4; 12–22 pmol/L
of fT4; 1.3–3.1 nmol/L of T3; 3.1–6.8 pmol/L of
fT3; 3.5–77 mg/L of Tg; borderline value of 34
IU/mL of TPOAb and threshold value of 115 IU/mL
of TgAb. Lower limit of TgAb measurement is 10.00
IU/mL. Values below the lower detection limit are
reported as <10.00 IU/mL. Reliability of the mea -
surement results was regularly checked through the
assessment of appropriate controls and application of
internal and external quality control principles.
Statistics
All calculations were performed using MedCalc
v. 12.1.4.0 (MedCalc software, Belgium). The Kol -
mogorov–Smirnov test was used to test normality.
Outliers were identified and omitted using the Tukey
method incorporated into the MedCalc software (7,
8). TSH, fT4 and fT3 values were normally distributed
variables. After logarithmic transformation of the non-
normally distributed variables, T4, T3, Tg and TPOAb
also achieved normality. For TgAb, normality was not
achieved even after the logarithmic transformation.
For the parameters with normal distribution (with or
without log transformation) we calculated both the
central 95% of the distribution and the 90% confi-
dence limits on both ends. Also, we calculated the
values of the 2.5th and 97.5th percentiles, with 90%
confidence intervals for lower and upper limits, as rec-
ommended by the IFCC (CLSI C28-A3). We analyzed
different groups according to gender by Student t test
and age groups by ANOVA test.
Results
Women were the majority in the group of sub-
jects for reference values (68%). The median age of
subjects was 39; the youngest person was 19, and
the oldest person was 70. The reference intervals are
shown in Table I. We found a significant difference of
TSH values (p<0.05) in the third, fourth and fifth
decade of life and significant difference of fT3 values
in the third and fifth decade of life (Table II). A sta -
tistically significant difference (p<0.05) was found
between males and females for fT4, T3 and fT3
(Table III). Distribution values of the thyroid parame-
ters are shown in Figure 1 and Figure 2.
Discussion
The reference values obtained in our research
on the population of the Republic of Srpska vary sig-
nificantly from the values recommended by the man-
ufacturer of reagents that we use in our laboratory
(9). The reference intervals (RI) for TSH obtained on
different populations and different analyzers show sig-
nificant differences in the lower and upper limits of RI
ranging from 0.17 to 0.6 and also from 3.63 to 5.95
mIU/L (10–14). Our results are not in accordance
with these and the results of many other studies,
where the upper TSH values were 3.6 mIU/L (15,
16), 3.35 mIU/L (17), 3.77 mIU/L (18), 3.37 mIU/L
(19), and 3.7 mIU/L (20). Although these studies
used ultrasound to rule out non-obvious or potential
abnormalities of the thyroid gland, this should not
be the reason for non-compliance with our results,
because there are no recommendations for necessary
ultrasound examination of the thyroid gland by the
NACB (6). Our results are not similar to the results of
studies in which ultrasound was not used for the
assessment of patients’ health status (21, 22). The
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Table I Reference values of the thyroid gland parameters.
Table II Thyroid parameters in different age groups.
⎯x, mean value; SD, standard deviation; n, number of subjects; TSH, thyrotropin; T4, total thyroxine, fT4 free thyroxine; T3, total
triiodothyronine; fT3, free triiodothyronine; Tg, thyroglobulin;  TPOAb, thyroid peroxidase; TgA, thyroglobulin antibody.
The values are presented as arithmetic mean ± standard deviation and geometric mean (95% CI) for variables marked with *.
ANOVA test was used. Abbreviations:  n, number of subjects; p, level of significance.
Parameter Groups n Mean values Different (p<0.05) from group
TSH (mIU/L)* 1 (age ≤30 years) 46 2.36 (2.03/2.73) 2,3
2 (age 31–40 years) 84 1.79 (1.62/1.98) 1
3 (age 41–50 years) 40 1.77 (1.49/2.10) 1
4 (age 51–60 years) 36 2.15 (1.83/2.50) –
5 (age >60 years) 18 2.39 (1.84/3.10) –
T4 (nmol/L)* 1 (age ≤30 years) 46 94.57 (91.22/98.03) –
2 (age 31–40 years) 85 96.12 (93.55/98.76) –
3 (age 41–50 years) 41 95.15 (89.97/100.62) –
4 (age 51–60 years) 36 97.97 (94.21/101.89) –
5 (age >60 years) 19 103.28 (96.55/110.49) –
fT4 (pmol/L) 1 (age ≤30 years) 48 16.60±1.85 –
2 (age 31–40 years) 84 16.29±1.94 –
3 (age 41–50 years) 40 15.89±2.24 –
4 (age 51–60 years) 36 15.50±1.82 –
5 (age >60 years) 19 16.29±1.93 –
T3 (nmol/L)* 1 (age ≤30 years) 47 1.65 (1.57/1.74) –
2 (age 31–40 years) 86 1.64 (1.58/1.70) –
3 (age 41–50 years) 41 1.55 (1.45/1.67) –
4 (age 51–60 years) 36 1.65 (1.57/1.73) –
5 (age >60 years) 19 1.64 (1.52/1.78) –
fT3 (pmol/L) 1 (age ≤30 years) 46 5.45±0.55 3
2 (age 31–40 years) 85 5.22±0.52 –
3 (age 41–50 years) 41 5.05±0.74 1
4 (age 51–60 years) 36 5.25±0.43 –
5 (age >60 years) 19 5.05±0.57 – 
Parameter n Reference interval
Parametric method Non-parametric method
-1.96 SD
Lower limit of 
95% distribution
⎯x +1.96 SD
Upper limit 
of 95% 
distribution
0.025
2.5 
Percentile
0.50
Median
0.975
97.5 
Percentile
TSH (mIU/L) 224 0.75                   1.99            5.32 0.65                1.96               5.39
T4 (nmol/L) 228 73.49                 96.34        126.30  73.01              96.22           127.70
fT4 (pmol/L) 227 12.29                 16.16          20.03 12.41              16.06             20.18           
T3 (nmol/L) 229 1.15                   1.63            2.32 1.17                1.62               2.40
fT3 (pmol/L) 226 4.11                   5.22            6.32 4.09                5.25               6.33
Tg (mg/L) 120 3.63                   9.72          26.00    3.48                9.51             27.58
TPOAb (mIU/L) 120 5.17                   9.65          18.02 5.00                9.65             18.81
TgAb (mIU/L) 120 - <10                10.00             98.00       
reference values of thyroid hormones are dependent
on the population, methodology and apparatus on
which the analysis is performed, as our study con-
firmed (23–26).
Also, the high prevalence of subclinical hypothy-
roidism (27) interferes with the proper selection of
healthy people in order to create reference values. A
limiting factor could be that the sampling time is not
standardized, as pointed out in the study of Mirjanic-
Azaric et al. (28). Further, it is known from the Middle
Ages that the Balkan region is strumogenic, and
recent researches in the Republic of Srpska (29) indi-
cated a lack of iodine in the diet, which could certain-
ly affect some reference values for TSH in the
Republic of Srpska. Nevertheless, it is interesting that
our results do not correspond to the RI population of
the Re public of Serbia (0.75–5.32 vs. 0.42–3.67
mIU/L), although they used an indirect method of
determining the reference values in their study (30).
It is important to indicate that the study of Hollowell
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Figure 1 Distribution of TSH, T4 and fT4 values
Table III Thyroid parameters in different gender groups.
The values are presented as arithmetic mean ± standard deviation and geometric mean (95% CI) for variables marked with *.
Student’s t test was used for comparison. Abbreviations: n, number of subjects; p, level of significance.
Parameter
Male Female  p
n Mean values n Mean values
TSH (mIU/L)* 73 2.09 (1.87/2.34) 151 1.95 (1.80/2.11) 0.322
T4 (nmol/L)* 72 95.08 (91.95/98.32) 155 97.16 (95.13/99.24) 0.266
fT4 (pmol/L)* 73 16.48 (16.00/16.97) 154 15.83 (15.54/16.14) 0.023
T3 (nmol/L)* 74 1.72 (1.66/1.79) 155 1.59 (1.54/1.63) <0.001
fT3 (pmol/L) 72 5.46±0.56 155 5.12±0.55 <0.001
et al. (3), as one of the rare studies which has shown
consistency with our research in terms of the upper
limit of the reference range for TSH, refers to the
results obtained for the white race in the United
States of America with reagents of the same manu-
facturer: 0.75–5.32 vs. 0.48–5.73 mIU/ L. Also,
laboratory guidelines are published today which show
that more than 95% of normal people have TSH
below 2.5 mIU/L (31) which cannot be said for our
group of respondents (Figure 1). The establishing of
more precise and more accurate RI for TSH has
important implications both for retrieval as well as for
the treatment of diseases of the thyroid gland.
Our study revealed very high similarity to the ref-
erence value obtained with the value of fT4 listed by
the manufacturer i.e. 12–20 pmol/L vs. 12–22 pmol/L
(9), while for the other reference values of hormones
T4, T3 and fT3 this was not the case. Some other
studies (32–34) showed large discrepancies with our
obtained values, which might be the result of all
those facts previously listed for TSH. The best coher-
ence of our reference values for T4 and T3 with the
reference values of hormones in the population of the
Republic of Serbia (30) was achieved for the follow-
ing T4: 73–126 vs. 66.0–136.10 nmol/L and T3:
1.15–2.32 vs. 1.10–2.39 nmol/L. For fT4 and fT3,
there is a huge difference: 12.29–20.03 vs. 10.20–
18.40 pmol/L and 4.11–6.33 vs. 3.17–5.59 pmol/L.
Tg reference interval was set for the development of
reference values for Tg according to the guidance,
except that we included in the group persons up to 50
years. Inter-individual variations are particularly high
for the serum concentration of Tg, because there are
differences in the weight of the thyroid gland in differ-
ent individuals, the status of TSH, and there are also
conditions associated with thyroid injury (thyroiditis) –
all of these conditions are affected by the serum con-
centration of Tg (31). Although there is statistically
significant difference in the values of TSH and fT3
between different age groups (Table II), we cannot say
that our study is consistent with the results of other
studies (35–37) in which the levels of TSH and free T3
gradually declined in older age. When we analyzed the
TSH and T4 levels in the male and female population,
we found no statistically significant difference between
these two groups, but for the fT4, T3 and fT3 values
we found significant difference (Table III). On the basis
of currently available data, we cannot fully explain this
difference. Nevertheless, the magnitude of significant
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Figure 2 Distribution of T3, fT3, Tg and TPOAb values.
differences was small, suggesting that gender-specific
reference intervals are not necessary. Since Tg is
dependent on the intake of iodine, it is necessary to
create its own reference range. In countries with
iodine deficiency, the mean value of Tg of the popula-
tion and the upper Tg reference limit could be in -
creased in relation to the degree of iodine deficiency.
Yet, it is a big surprise for us that there is so large
a difference in the upper limit of the reference value
for thyroglobulin in our population in relation to the
reference values recommended by the manufacturer
of reagents, ie. 4–26 vs. 5–77 mg/L. Also, an un -
expected distribution of Tg values can be seen in
Figure 2. Therefore, we recommend new research to
confirm the obtained results, but this time with a larg-
er number of subjects and the use of indirect method
which is much cheaper and also recommended by the
NACB.
The reference interval for TPOAb and TgAb was
determined by the recommendations of the NACB in
order to minimize the inclusion of people with a pre-
disposition to autoimmune thyroid disease, except the
fact that we included subjects up to age of 50 in order
to achieve the recommended number of respondents.
Our results for TPOAb are significantly lower than
the values recommended by the manufacturer of
reagents that we use.
In one study (38), the upper limit of our refer-
ence interval for TPOAb and TgAb almost coincides
with the values of their subjects, i.e. 18 vs. 19 IU/L
and 98 vs. 99 IU/L. Finally, the determination of pre-
cise and accurate RI for thyroid hormones will enable
the conditions for the establishment of proper diagno-
sis and better treatment of the thyroid gland than
using RI made by the manufacturer.
Conclusion
The establishing reference values for the popu-
lation of the Republic of Srpska were significantly dif-
fered from the recommended values by the manufac-
turer of reagents (Roche Diagnostics). The results
showed that laboratories have to establish their own
reference values in order to set up a proper diagnosis,
as well as to treat patients successfully.
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